Enzo Biochem (ENZ)
0.6360 -0.0171 (-2.62%) 11:13 ET [NYSE]
0.6356 x 100 0.6425 x 100
Realtime by (Cboe BZX)
0.6356 x 100 0.6425 x 100
Realtime 0.6344 -0.0187 (-) 09:26 ET
for Mon, Jan 27th, 2025
Fiscal Year End Date: 07/31
07-2019 | 07-2018 | 07-2017 | 07-2016 | 07-2015 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 60,146 | 60,041 | 64,167 | 67,777 | 18,109 |
Receivables | 10,738 | 13,147 | 15,180 | 14,592 | 18,759 |
Inventories | 7,842 | 7,278 | 7,047 | 6,971 | 7,396 |
TOTAL | $81,453 | $83,200 | $89,084 | $91,397 | $46,486 |
Non-Current Assets | |||||
PPE Net | 14,254 | 7,636 | 7,901 | 8,214 | 7,948 |
Intangibles | 8,484 | 9,338 | 10,347 | 11,874 | 13,607 |
Other Non-Current Assets | 2,449 | 1,486 | 333 | 336 | 353 |
TOTAL | $25,187 | $18,460 | $18,581 | $20,424 | $21,908 |
Total Assets | $106,640 | $101,660 | $107,665 | $111,821 | $68,394 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | N/A | N/A | 1,557 | 3,013 |
Accounts payable and accrued liabilities | 7,256 | 9,516 | 10,350 | 9,857 | 8,762 |
Accrued Expenses | 8,362 | 10,054 | 6,720 | 8,211 | 11,297 |
Other current liabilities | 391 | 616 | 740 | 943 | 886 |
TOTAL | $16,009 | $20,186 | $17,810 | $20,568 | $23,958 |
Non-Current Liabilities | |||||
Long Term Debt | 4,179 | N/A | N/A | N/A | N/A |
aiOther Non-Current Liabilities | 424 | 353 | 983 | 1,699 | 1,793 |
TOTAL | $4,603 | $353 | $983 | $1,699 | $1,830 |
Total Liabilities | $20,612 | $20,539 | $18,793 | $22,267 | $25,788 |
Shareholders' Equity | |||||
Shares Outstanding, K | 47,557 | 47,182 | 46,548 | 46,268 | 46,062 |
Common Shares | 476 | 472 | 465 | 463 | 461 |
Retained earnings | -249,732 | -252,221 | -241,900 | -239,396 | -284,682 |
Other shareholders' equity | 2,580 | 2,100 | 2,013 | 2,199 | 1,861 |
TOTAL | $86,028 | $81,121 | $88,872 | $89,554 | $42,606 |
Total Liabilities And Equity | $106,640 | $101,660 | $107,665 | $111,821 | $68,394 |